548 related articles for article (PubMed ID: 27895417)
1. Glycoproteins and glycoproteomics in pancreatic cancer.
Pan S; Brentnall TA; Chen R
World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
[TBL] [Abstract][Full Text] [Related]
2. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.
Pan S; Chen R; Tamura Y; Crispin DA; Lai LA; May DH; McIntosh MW; Goodlett DR; Brentnall TA
J Proteome Res; 2014 Mar; 13(3):1293-306. PubMed ID: 24471499
[TBL] [Abstract][Full Text] [Related]
3. The next "sweet" spot for pancreatic ductal adenocarcinoma: Glycoprotein for early detection.
Xu Y; Wang Y; Höti N; Clark DJ; Chen SY; Zhang H
Mass Spectrom Rev; 2023 Mar; 42(2):822-843. PubMed ID: 34766650
[TBL] [Abstract][Full Text] [Related]
4. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
5. A case for protein-level and site-level specificity in glycoproteomic studies of disease.
Schumacher KN; Dodds ED
Glycoconj J; 2016 Jun; 33(3):377-85. PubMed ID: 27007620
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma.
Llop E; E Guerrero P; Duran A; Barrabés S; Massaguer A; José Ferri M; Albiol-Quer M; de Llorens R; Peracaula R
World J Gastroenterol; 2018 Jun; 24(24):2537-2554. PubMed ID: 29962812
[TBL] [Abstract][Full Text] [Related]
7. Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.
Raghunathan R; Sethi MK; Klein JA; Zaia J
Mol Cell Proteomics; 2019 Nov; 18(11):2138-2148. PubMed ID: 31471497
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
9. Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation.
Holst S; Belo AI; Giovannetti E; van Die I; Wuhrer M
Sci Rep; 2017 Nov; 7(1):16623. PubMed ID: 29192278
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive markers in pancreatic adenocarcinoma.
Le N; Sund M; Vinci A;
Dig Liver Dis; 2016 Mar; 48(3):223-30. PubMed ID: 26769569
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics protocols in glycomics and glycoproteomics.
Tang H; Mayampurath A; Yu CY; Mechref Y
Curr Protoc Protein Sci; 2014 Apr; 76():2.15.1-2.15.7. PubMed ID: 24692013
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
13. Macrophages and pancreatic ductal adenocarcinoma.
Habtezion A; Edderkaoui M; Pandol SJ
Cancer Lett; 2016 Oct; 381(1):211-6. PubMed ID: 26708507
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6: a villain in the drama of pancreatic cancer development and progression.
Holmer R; Goumas FA; Waetzig GH; Rose-John S; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):371-80. PubMed ID: 25100121
[TBL] [Abstract][Full Text] [Related]
15. Glycomics, glycoproteomics and the immune system.
Kolarich D; Lepenies B; Seeberger PH
Curr Opin Chem Biol; 2012 Apr; 16(1-2):214-20. PubMed ID: 22221852
[TBL] [Abstract][Full Text] [Related]
16. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in mass spectrometry-based glycoproteomics.
Frost DC; Li L
Adv Protein Chem Struct Biol; 2014; 95():71-123. PubMed ID: 24985770
[TBL] [Abstract][Full Text] [Related]
18. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
Gaunitz S; Tjernberg LO; Schedin-Weiss S
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207636
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in glycoinformatic platforms for glycomics and glycoproteomics.
Abrahams JL; Taherzadeh G; Jarvas G; Guttman A; Zhou Y; Campbell MP
Curr Opin Struct Biol; 2020 Jun; 62():56-69. PubMed ID: 31874386
[TBL] [Abstract][Full Text] [Related]
20. Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers.
Koay EJ; Amer AM; Baio FE; Ondari AO; Fleming JB
Cancer Lett; 2016 Oct; 381(1):237-43. PubMed ID: 26806807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
